Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study

NCT07266012 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

NCT NCT07266012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Observational
Overall status
Completed
Start date
May 7, 2025
Completion date
November 21, 2025
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension (pah), pulmonary arterial hypertension (pah) (who group 1 ph)